Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

31 Oct 2024 07:00

RNS Number : 3193K
Kainos Group plc
31 October 2024
 

31 October 2024

 

Kainos Group plc

("Kainos" or the "Company")

 

Trading Update

 

Kainos Group plc (KNOS), a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services, and Workday Products, today issues an update on trading since 2 September 2024 and updated guidance for the year ending 31 March 2025.

 

Whilst the Workday Products business continues to grow very strongly, our Digital Services and Workday Services divisions continue to be affected by the macro-economic environment and related delays in client decision-making. Considering these factors, the Board has moderated its expectations for the second half of the year and now expects that for the year ending 31 March 2025, we will deliver revenues moderately below current market consensus with the majority of the reduction flowing through to adjusted PBT. 

 

Divisional performance and outlook

· Our Workday Products division continues to deliver growth, with a very strong performance recorded in the first half of the year. The July announcement of our expanded Workday partnership has further enhanced our growth prospects, reflected in our increased ARR target of £200m by 2030.

 

· In Digital Services, there is sustained demand from our Public Sector clients, but there has been continuing delays around decision-making as our clients await clarity on the new government's spending priorities. These delays have been more pronounced in the last few weeks in anticipation of the publication of the new budget. Although we anticipate heightened levels of activity in the weeks ahead, we are dependent on decisions being made before the main mobilisation phases for these contracts.

 

· As outlined in our September Trading Statement, our Workday Services division has continued to win new contracts, however, the number and value of these new contracts have been lower than in previous periods and has resulted in a decline in revenue during the last six months. We continue to anticipate increased activity in the second half of the year but are being more cautious around the timing which will impact recovery. 

 

Proactive Management

Whilst these changes to our expectations are about delays rather than cancellations, we nonetheless continue to be focused on maintaining prudent cost control measures, reducing discretionary spending, minimising our level of contractors, while reallocating staff to our current high growth areas in Workday Products and in the Healthcare Sector of Digital Services.

 

Share Buyback Programme

Given the strength of the Company's balance sheet, the Board intends to approve a share buyback programme, full details of which will be given alongside the interim results for the six months ended 30 September 2024 which will be announced on 11 November 2024.

 

Outlook Summary

Notwithstanding this backdrop for FY2025, the Board continues to believe that we are well positioned in our core markets, which offer substantial growth opportunities in all our divisions and that we are maintaining the appropriate balance between investment for future growth, international expansion and profitability.

 

 

 

* Note: Company compiled consensus is based on known sell side analyst estimates that were updated following the Trading Update in September 2024. The ranges are: Revenue £375.5m - £392.0m and Adjusted PBT £75.0m - £79.7m. The respective consensus figures are £388.8m and £78.8m. FY2024 reported revenue was £382.4m and adjusted PBT was £77.2m.

 

ENDS

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +4420 7597 5970

Patrick Robb / Nick Prowting / Ben Griffiths

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning

 

About Kainos Group plc

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions: Digital Services, Workday Services, and Workday Products.

 

· Digital Services develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users.

 

· Workday Services specialises in the deployment of Workday, Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

 

· Workday Products develops products that complement Workday. Our Smart product suite, including Smart Test (for automated testing), Smart Audit (for compliance monitoring), and Smart Shield (for data masking), and Employee Document Management, are used by more than 500 customers globally.

 

Our people are central to our success. We employ more than 2,900 people in 22 countries across Europe and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURUURSAUROUA
Date   Source Headline
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast
1st Aug 20234:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.